247 related articles for article (PubMed ID: 26941014)
21. Female Estrogen-Related Factors and Incidence of Basal Cell Carcinoma in a Nationwide US Cohort.
Cahoon EK; Kitahara CM; Ntowe E; Bowen EM; Doody MM; Alexander BH; Lee T; Little MP; Linet MS; Freedman DM
J Clin Oncol; 2015 Dec; 33(34):4058-65. PubMed ID: 26527779
[TBL] [Abstract][Full Text] [Related]
22. UV dose determines key characteristics of nonmelanoma skin cancer.
Ramos J; Villa J; Ruiz A; Armstrong R; Matta J
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2006-11. PubMed ID: 15598755
[TBL] [Abstract][Full Text] [Related]
23. Exclusive development of a single type of keratinocyte skin cancer: evidence from an Australian population-based cohort study.
Keim U; van der Pols JC; Williams GM; Green AC
J Invest Dermatol; 2015 Mar; 135(3):728-733. PubMed ID: 25233075
[TBL] [Abstract][Full Text] [Related]
24. XPA, haplotypes, and risk of basal and squamous cell carcinoma.
Miller KL; Karagas MR; Kraft P; Hunter DJ; Catalano PJ; Byler SH; Nelson HH
Carcinogenesis; 2006 Aug; 27(8):1670-5. PubMed ID: 16513681
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
[TBL] [Abstract][Full Text] [Related]
26. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous keratinocyte cancers of the head and neck: Epidemiology, risk factors and clinical, dermoscopic and reflectance confocal microscopic features.
Lee KJ; Soyer HP
Oral Oncol; 2019 Nov; 98():109-117. PubMed ID: 31585338
[TBL] [Abstract][Full Text] [Related]
28. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis.
Flohil SC; van der Leest RJ; Arends LR; de Vries E; Nijsten T
Eur J Cancer; 2013 Jul; 49(10):2365-75. PubMed ID: 23608733
[TBL] [Abstract][Full Text] [Related]
29. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis.
Asgari MM; Tsai AL; Avalos L; Sokil M; Quesenberry CP
JAMA Dermatol; 2020 Oct; 156(10):1066-1073. PubMed ID: 32785626
[TBL] [Abstract][Full Text] [Related]
30. Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta-analysis of observational studies.
Tang H; Fu S; Zhai S; Song Y; Asgari MM; Han J
Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):279-288. PubMed ID: 29318704
[TBL] [Abstract][Full Text] [Related]
31. Age group-specific changes in keratinocyte cancer treatment rates in Australia, 2012-2021: a retrospective cohort study based on MBS claims data.
Olsen CM; Pandeya N; Neale RE; Whiteman DC
Med J Aust; 2024 May; 220(9):472-479. PubMed ID: 38685827
[TBL] [Abstract][Full Text] [Related]
32. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
33. The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal study.
Valery PC; Neale R; Williams G; Pandeya N; Siller G; Green A
J Investig Dermatol Symp Proc; 2004 Mar; 9(2):148-51. PubMed ID: 15083782
[TBL] [Abstract][Full Text] [Related]
34. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
35. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001.
Hayes RC; Leonfellner S; Pilgrim W; Liu J; Keeling DN
J Cutan Med Surg; 2007; 11(2):45-52. PubMed ID: 17374314
[TBL] [Abstract][Full Text] [Related]
36. Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.
Robinson SN; Zens MS; Perry AE; Spencer SK; Duell EJ; Karagas MR
J Invest Dermatol; 2013 Aug; 133(8):1950-5. PubMed ID: 23344461
[TBL] [Abstract][Full Text] [Related]
37. Nonmelanoma skin cancer in an Irish population: an appraisal of risk factors.
Healy E; Collins P; Barnes L
Ir Med J; 1995; 88(2):58-9. PubMed ID: 7775148
[TBL] [Abstract][Full Text] [Related]
38. Citrus consumption and risk of basal cell carcinoma and squamous cell carcinoma of the skin.
Wu S; Cho E; Feskanich D; Li WQ; Sun Q; Han J; Qureshi AA
Carcinogenesis; 2015 Oct; 36(10):1162-8. PubMed ID: 26224304
[TBL] [Abstract][Full Text] [Related]
39. [Epidemiology of epithelial skin cancers].
Bulliard JL; Panizzon RG; Levi F
Rev Med Suisse; 2009 Apr; 5(200):882, 884-8. PubMed ID: 19438088
[TBL] [Abstract][Full Text] [Related]
40. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
